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INTRODUCTION
Cytokinins were first discovered as cytokinetic factors in tobacco
pith tissue (Jablonski and Skoog, 1954). Cytokinins are basically
N6-isopentenylated adenine derivatives and have been arbitrarily defined
as compounds that stimulate cell cytokinesis and growth in certain plant
tissues (review Kende, 1971).
The effects of these compounds on plants have been extensively
studied.

Cytokinins are known to influence all stages of plant develop-

ment starting from the initial stages of cell division to the more
mature stages of organ formation, differentiation and senescence.
Cytokinins function in plant development in conjunction with other plant
hormones such as auxins and gibberellins.
Apical dominance, a phenomenon seen in plants by which the growth
and development of terminal buds are favored over that of lateral buds,
can be removed by cytokinins (Wickson and Thimann, 1956).

Evidence

abounds to show that cytokinins also promote the process of flowering
and fruit development (Werdell and Skoog, 1969; Negi and Olmo, 1966;
Van Overbeek, 1968: Tepfer

et~.,

1966).

Cytokinins are also known to occur in bacteria and fungi that are
parasitic or symbiotic in plants.

Corneybacterium fascians causes a

disease in plants called witches broom.

This disease is characterized

by the formation of swollen internodes and a release from apical

1
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dominance.

Thimann and Sachs (1966) were able to duplicate the symptoms

of fasciation by application of cytokinins to the plants.

Armstrong and

his co-workers (1976) have successfully isolated and identified the
cytokinin present in the Corneybacterium fascians filtrate.

The same

phenomenon is also seen in the formation of nodules in legumes by
Rhizobium.

Phillips and Torrey (1970) were able to show the presence of

cytokinins in the Rhizobium species.

Agrobacterium tumefacians causes

crown gall disease in plants and the tumor tissue of the infected plants
contains high levels of cytokinins (Miller, 1975).
Cytokinins stimulate the activity of many different enzymes, one
of which is nitrate reductase (Hirshberg

et~·,

1972).

In some cases

they are also known to decrease enzyme activity (Martin and Thimann,
1972; Birmingham and Mclachlan, 1972; Shibaoka and Thimann, 1970).
Several studies have also shown that cytokinins stimulate the formation
of polyribosomes (Short
Fosket, 1977).

et~.,

1974; Tepfer

_et~.,

1975; Muren and

In addition to stimulation of protein and RNA synthesis,

cytokinins also cause an increase in DNA synthesis.

Metabolism,

respiration and biosynthesis of growth factors are also influenced by
cytokinins in plants.
to plant cells.

The effect of cytokinins is not merely restricted

Mammalian cells have also been shown to respond to

cytokinins, though it is not known that these effects are related
directly to those seen in plants.

These compounds have been found to

play a role in the inhibition of platelet aggregation (Kikugawa
1973).

et~.,

Groytth of tumor cells was al so inhibited by cytokinins in

several in vivo and in vitro studies (Fleysher

et~.,

1968; Fleysher,
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1972; Rathbone and Hall, 1972; Grindley

et~·,

1973).

Cytokinins can

also act as immunosuppresive agents (Hacker and Feldbush, 1969).

These

plant hormones also competitively inhibit beef heart cyclic AMP
phosphodiesterase and glucose-6-phosphate dehydrogenase (Hecht
1974).

et~··

In cultured fibroblasts, cytokinins induce cell elongation,

decrease cell motion and increase cell adhesion to the substratum
(Johnson et~ .• 1974). N6-( .6. 2-isopentenyl) adenosine (i 6A), a potent
cytokinin, and several other cytokinins have been found to both
stimulate and inhibit the growth of phytohemagglutinin - treated human
lymphocyte cells depending upon the stage of cell cycle at which the
cytokinin was administered (Gallo

et~··

1972).

These workers also

speculated that cytokinins are involved with cyclic AMP metabolism,
based on the observation that cyclic AMP exerted similar effects on
lymphocytes.
Cytokinins are generally N6-substituted adenine derivatives and
high cytokinin activity is limited to N6-monosubstituted compounds.
Basically the structure of cytokinins exhibiting high order activity is
made up of an intact adenine molecule with N6-substituted side chain of
moderate size. Substitution of the nitrogen atom at the N6-position
with either O or S leads to a loss of over 90% in cytokinin properties
(Skoog et~·· 1967).

Modification in the adenine moiety also causes a

dramatic decrease in cytokinin activity though the question of whether
adenine itself has cytokinin activity has not been resolved (review
Skoog and Armstrong, 1970).

4

The nature of the side chain affects the cytokinin activity of the
molecule.

Using 6-n-alkyl-aminopurines (Skoog

et~··

1967), it was

found that the cytokinin activity of the compound increases with each
additon of C atoms to the side chain up to an optimum of five C atoms.
unsaturation in the side chain also confers maximum activity. This can
be seen in two potent cytokinins, i 6A and zeatin, both of which have
unsaturation of the side chains.
ten-fold decrease in activity.

The saturated counterparts show a
The isopentenyl group as a side chain is

generally the best for conferring high cytokinin activity to the compound, though ring substituents such as the benzyl ring or furfuryl ring
are also effective.

Studies have failed to determine the presence of

any specific chemical group that is necessary for activation of the
cytokinin.

In general, cytokinins lack structural specificity and will

tolerate most changes or substitutions in the parental structure and
still exhibit cytokinin properties.

The general consensus, therefore,

is that it is the exogenous quality of the molecule itself rather than
any specific reactive group that confers cytokinin activity to a
molecule.
Several compounds of non-purine derivatives have also been found
to have cytokinin activities; the most important of which are the
phenylurea derivatives.

First demonstrated to show cytokinin activity

by Steward and Shantz (1956), phenylurea derivatives satisfy the basic
minimal requirement for activity.

This basic structural requirement,

the presence of an intact -NH-CO-NH- bridge with a phenyl ring attached,
is satisfied in phenylurea derivatives.

5

Cytokinins can occur freely or bound to specific tRNAs.

Free

cytokinins in general occur mostly in higher plants in the rapidly
growing tissues such as young fruits, seeds, meristematic region of
roots, root exudate, autonomous callus tissues, and crown gall tumors
(review Kende, 1971).

They have also been found in certain plant

pathogens, parasites and symbionts (review Letham and Palni, 1983).
The relationship between free cytokinins and cytokinin-bound tRNAs
has been the focus of several studies.

One of the controversies in the

area is the origin of free cytokinins.

Do free cytokinins arise from

the turnover or degradation of tRNA-bound cytokinin or are they produced
de~

via a pathway independent of tRNA turnover?

Chen and Hall

(1969) forwarded the model of cytokinins in tRNA as being responsible
for the maintenance of the proper level of free i 6A in tobacco pith
tissue.

In this model, the cytokinin-bound tRNA is not biologically

active and only exerts its cytokinin activity upon release from the tRNA
molecule.

In an...'!..!!. vitro study, Armstrong

et~.,

(1976), was able to

demonstrate the release of the cytokinin from the modified tRNAs and
rRNAs of tobacco callus using nucleases.

An alternate pathway other

than from tRNA turnover for the production of free cytokinins has been
suggested from the study of Short and Terry (1972).

These workers found

27 times more free cytokinins than the amount detected in the tRNAs in
root apices and seedling peas.

The implication here is that unless the

turnover rate of tRNA degradation is extremely high, the free cytokinin
is obtained via an alternative route.

Taya and his co-workers (1978),

reported the existence of a cytokinin biosynthetic pathway not related

6

They also showed that 5 1 -AMP i s
2
the actual acceptor molecule for the i sopentenyl group: 5'AMP + L\ -ipp
6
. + Pi. A study by Laloue and Ha 11
i 6AMP + PPi, i AMP -7 i.6Ad enos1ne

to tRNA degradation in D. discoideum.

(1973) yielded evidence suggesting that Rhizopogan rosealus is capable
of producing free cytokinins by a pathway other than from the tRNA
degradation.

In callus cells of moss sporophytes supplied with radio-

active adenine,

labelled cytokinin with the same chromatographic
properties as N6- ( 6. 2-isopentenyl) adenine was found. No radioactive
~

cytokinin, however, was found in the tRNA of the callus cells, suggesting the existence of an alternate pathway for the production of free
cytokinins.

Chen and his co-workers (1976), using tobacco tissue, were

able to show that the tissue is capable of synthesizing i 6Ade and its
derivatives from adenine and the adenosine analog.

A recent study found

that two yeast mutants, mod5-1 from S. cerevisiae and sinl-26 from
S. pombe lacking isopentenylated tRNAs, showed no significant differences in the levels of free cytokinins present when compared to wild
type yeasts (Zahareas, 1983).
Another area of intense debate has been the question of whether
free cytokinins exert their hormonal response through their presence in
tRNA.

Several studies have shown that free cytokinin can be incorpo-

rated into tRNA.

Tobacco callus and soybean tissue requiring cytokinins

for growth have been found to be capable of incorporating radioactivelylabelled 6-benzylaminopurine into RNAs (Fox and Chen, 1967; Walker and
Leonard, 1974).

Walker and Leonard were able to show that incorporation

of the cytokinin into the tRNAs involved the intact comp'ound with a

~
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level of incorporation of about 1 N6-benzylaminopurine for every 10 4
tRNA molecules.
Kerde and Tavares (1968) used t-benzylamino-9-methylpurine to show
that inhibition of incorporation into RNA did not affect biological
activity of the cytokinin in soybean callus tissue.

Retarding leaf

senescence, a known property of cytokinins was found to be unreleated to
incorporation of the free cytokinin into tRNA (Richmond et al., 1970).
Certain cytokinins, because of their structural features, are not likely
to be incorporated into tRNA, and as yet are still thought to be capable
of exerting hormonal activity (Skoog et al., 1973).

The evidence above

shifted the focus of attention away from tRNAs as the site of free
cytokinin action.
The mystery surrounding the mode of action of cytokinins has not
been unravelled, though the discovery of proteins that specifically bind
cytokinins has opened a promising line of investigation.

Berridge and

his co-workers (1970) first reported cytokinin binding to 83 s ribosomes
in Chinese cabbage.

Cytokinin binding to ribosomes was later also

reported in wheat germ (Fox and Erion, 1975).

These workers also

detected the presence of two types of binding sites, one of which had a
high affinity for substances with cytokinin activity and readily washed
from the ribosomes with 0.5 M potassium chloride.

A positive correla-

tion was found between the extent of binding and the activity of various
cytokinins, cytokinin analogues and purine derivatives (Berridge
1970; Fox and Erion, 1975).

et~··

A more recent study showed that the

cytokinin-binding protein in wheat germ ribosomes had a molecular weight

8

of approximately 140,000 daltons with three subunits of 54,000, 50,000
and 40,000 daltons.

This cytokinin-binding protein is found to be

specific for s?me N6-substituted adenines that exhibit cytokinin properties with the exception of zeatin or other hydroxylated derivaties
(Erion and Fox, 1977).
Polya and Bowman (1979) presented evidence against a receptor role
for this protein.

They found that cytokinin-binding proteins had

considerable affinity for a number of non-purine compounds, an unlikely
trait for a hormone receptor, since one expects a receptor to recognize
a limited set of structural determinants.

The authors in turn suggested

a catalytic function and a cytokinin sequestering function as a more
plausible role for the proteins.
Cytokinins, as mentioned earlier, also occur as minor components
of certain species of tRNA.

Cytokinin-active ribonucleosides have been

found in the tRNA or virtually all organisms tested (Hall, 1970).

The

presence of isopentenyladenosine is apparently universal, and so far it
is the only cytokinin found in animals.

Sequence analyses have detected

the presence of only one cytokinin base per molecule of tRNA (Barrel and
Clark, 1974).

The modified base is normally found adjacent to the 3'

end of the anticodon.

Cytokinin modified tRNAs occur strictly in the

species of tRNAs which decode codons starting with U. In E.coli, all
tRNA species which correspond to codons starting with U have been found
to contain a cytokinin (Armstrong et~·· 1969; Nishimura et~·· 1969;
Yamada et~·· 1971).

In animal tRNAs tested, Skoog and Armstrong

(1970) found cytokinin modified bases only in serine tRNA species.

In

9

yeasts, the tRNA species containing cytokinin bases are those that code
for serine (Zachau

et~-·

cysteine (Armstrong,

1966), tyrosine (Madison and Kung, 1967) and

et~-·

1969).

Base Y has also been found in yeast

and wheat germ phenylalanine tRNA, occuring in the position adjacent to
the anticodons on the 3 1 end (Dudeck
1967).

et~··

1969; RajBhandary

et~-·

Acid-promoted excision of Base Y from yeast and wheat germ

phenylalanine tRNAs resulted in compounds which showed weak cytokinin
activity (Hechet,

et~-·

1970).

A number of investigations have examined the role of these
modified tRNAs in the enhancement of translational efficiency.

Fitler

and Hall (1966) successfully changed the chemical moiety in modified
6
yeast-seryl-tRNA using aqueous iodine and found that the loss of i A
interferes with the binding of the seryl-tRNA to the ribosome-messenger
RNA complex.
affected.

The acceptance of serine residues though, was not

Gefter and Russell (1969) isolated three different forms of

suppressor tyrosine tRNA from E. coli.

The tRNAs differed only in the

extent of modification at the base adjacent to the anticodon.

It was

found that the fully modified tRNAs were most effective in supporting in
~protein

synthesis and ribosome binding.

The partially modified

tRNAs showed a slight reduction in in vitro protein synthesis and
ribosome binding, whereas the tRNAs with the unmodified

residues of

adenylic acid showed a marked reduction in their ability with respect to
Furuichi and Ukita (1970) using bisulfite treatment of
tRNA to chemically alter the i 6A at the 3 end of the anticodon, yielded
both processes.

1

results similar to those observed by Gefter and Russell (1969).
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Faulkner and Uziel (1971) found a reduction in the ability of iodinemodified phenylalanine tRNA from E. coli to function in in vitro
polyphenylalanine synthesis.
On the other hand, the results of the following two studies
suggested non-involvement of the modified nucleotides in protein synthesis.

Litwack and Peterkofsky (1971) prepared tRNA from a mevalonaterequiring mutant of Lactobacillus that was 50% deficient in i 6A by
limiting mevalonic acid concentration.

The i 6A deficient tRNAs when

compared with fully isopentenylated tRNA showed no distinguishable
differences in aminoacylation and ,in vitro protein synthesis.

Another

study using Mycoplasma phenylalanine tRNA, in which the nucleoside next
to the anticodon is not hypermodified, and a fully modified E. coli
phenylalanine tRNA, found no difference in the efficiencies of both
species of tRNA in in vitro protein synthesis (Kimball and Soll, 1974).
The authors suggested that subtle interactions that are lost under
in vitro conditions might exist.
Modified nucleotides have been shown to have a pronounced effect
on anticodon - anticodon interactions (Grosjean

et~··

1976).

Using

yeast phenylalanine tRNA and E. coli glutamine tRNA, which have
complementary anticodons, these workers found that modified nucleotides
play an important role in stabilizing anticodon - anticodon interactions.

Studies have also indicated the importance of modified bases

adjacent to anticodons in specificity of codon recognition (Gefter and
Russell, 1968; Parthasarathy, 1974).

Yarus (1982) formulated a theor-

etical framework of the extended anticodon whereby the loop and stem 3 1
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to the anticodon is employed to enhance the accuracy of selected pairing
with the appropriate codons.

_!!!.vivo studies by Laten

et~··

(1978)

and Janner et..!!_., (1980) found a correlation between a decreased suppression efficiency in mutant yeasts and a lack of isopentenylated
tRNAs. E. coli strains with a mia A mutation (which results in a loss
of i 6A in tRNA) showed reduced efficiency of suppression of UAG and UGA
nonsense mutations and reduced readthrough levels of UAG and UGA termination codons (Petrullo

et~··

1983).

UAA suppressors and readthrough

of UAA were unaffected, leading the authors to conclude that the mia A
mutation is itself a UAA.
The isopentenyl group of cytokinins is derived from mevalonate.
2
6
Using radioactively labelled mevalonate, N -( .6. -isopentenyl) adenosine
nucleotide has been identified as one of the products derived from
mevalonic acid (Chen and Hall, 1969; Fittler
1968).

Several studies (Chen, 1958; Bloch

et~··

et~·,

1968; Peterkofsky,

1959; Bloch, 1965)

have elucidated the pathway from mevalonic acid to sterols and other
compounds made up of isoprene units (Fig. 1).

Mevalonic acid is

converted enzymatically to a series of intermediates through which .6.. 2i sopentenyl pyrophosphate ( A 2-i pp) is produced (Chen, 1962). .6. 2-i pp
is the immediate precursor of N6-( A 2-isopentenyl) adenosine nucleotide
in the cytokinin modified tRNAs (Fittler et~ .• 1968; Kline et~ .•
1969) . .6. 2-i pp: tRNA ~ 2-i so pen tenyl transferase is the enzyme responsible for the transfer of 1:::,. 2-ipp to the specific adenosine residue in
tRNA.

This enzyme has been partially purified from yeast and rat liver

tissue (Kline et~ .. 1969) and E. coli (Rosenbaum and Gefter, 1972).

A

12
crude enzyme system was also extracted from tobacco pith tissue that
catalyzes the attachment of !:!. 2-ipp to an adenosine residue on the
performed tRNA (Chen and Hall, 1969). The immediate precursor of
3
3
b. 2-ipp is L::i. -ipp (Fig. 2).
6.. -isopentenylisomerase is the enzyme
responsible for the catalytic conversion of 6. 3-ipp to D..2-ipp.
A mutant of Saccharamyces cerevisiae, mod 5-1 has been isolated
and found to contain only 1.5% of the normal tRNA complement of i 6A
(Laten

et~··

1978).

Also incorporated in this strain was an adenine

dependent UAA nonsense mutation, ade 2-1, and an efficient UAA nonsense
suppressor, SUP7-o.

The partial loss of suppressor function in mod 5-1

makes the yeast strain adenine-dependent.

This trait enables one to

distinguish the mutant phenotypically from the wild type since the
accumulation of adenine metabolites confers a pinkish coloration to the
mutant colonies.
The lack of isopentenylated tRNAs in this mutant is a result of
the absence of an effective gene product.
to identify the missing product in mod

5-~

The purpose of this study is
in order to shed more light

on the nature of the mutation and its feasibility as a useful tool for
the study of modified tRNAs.

STATEMENT OF PROBLEM
An antisuppressor mutant of Saccharomyces cerevisiae or baker's
yeast, designated as mod5-1 was isolated and found to contain only 1.5%
of the normal tRNA complement of i 6A (Laten et al., 1978). The undermodification of the tRNAs in mod5-1 is a result of the absence of a
nuclear gene product, and this study attempts to identify the missing
gene product.

Since isopentenylation of tRNA is the end product of a

series of enzymatic reactions (Fig. 2), the mutant is most likely
defective in one of these reactions.

The defective enzyme is most

likely the last enzyme in the pathway, .c:::. 2-isopentenyl -b.2-ipp:
isopentenyltransferase.

A defect in enzymes further upstream should be

more deleterious to the mutant since the production of other key endproducts will be affected.

The mutation as such, has very little effect

on the cell other than reducing suppressor efficiency.

Growth of

mutants in both complex media and simple media at moderate (28°C) and
elevated (37°C) temperatures did not differ significantly from the
nonmutants; little difference in generation times and cell yields was
seen (Laten

et~··

1978).

The second most likely candidate for the

defective enzyme in this mutant is isopentenylpyrophosphate isomerase,
which is just one step upstream of ~ 2 -ipp:tRNA-isopentenyl-transferase

in the pathway for the production of isopentenylated tRNAs.

13
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In this study, assays for isopentenylpyrophosphate isomerase and
isopentenylpyrophosphate transferase activities were carried out. In
the isomerase assay, radioactive .6. 3-ipp was used to monitor the abilities of crude yeast enzyme extracts from mod5-1 and wild type yeasts to
convert 6 3-ipp to ..6. 2-ipp. In the transferase assay, radioactive
t:,.

3-ipp was again used, this time to monitor the~ vitro incorporation

of isopentenylpyrophosphate into mod5:.!. tRNAs using crude yeast enzyme
preparation from both the mod5-l strain and the wild type strain.
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Fig. 1 The pathway of sterol biogenesis.

MATERIALS AND METHODS
Yeast Cells
Yeast cells were grown in liquid YEPD media (1% yeast extract, 2%
peptone and 2% dextrose) at 30 0 C.

The cells grown to an absorbance of

2.0 - 3.0 at 625 nm, were centrifuged at 5900.[ for 15 minutes, washed
with distilled water and then harvested by recentrifugation.
The cells were stored frozen and used as needed.
Isolation of tRNA
1 ml of buffer A (0.04 M imidazole - HCl, pH 7.0, 0.1 M NaCl,
0.01 M MgC1

and 0.1 mM EDTA) and 1 ml of buffer-saturated phenol were
2
added per gram wet weight of frozen yeast cells. The mixture was
agitated for 1 hour and the phases separated by centrifugation.

The

aqueous phase was then re-extracted with an equal volume of phenol.
NaCl was added to the aqueous phase after the second extraction, to a
final concentration of 0.2M.

Two volumes of ice cold ethanol were then

added and the suspension was stored overnight at -20°c to precipitate
the nucleic acids.

After centrifugation at 12,000.[, the precipitate was

dissolved in a volume of buffer A corresponding in ml to about half the
original wet weight in grams of the cells.

The sample was then loaded

on a pre-equilibrated DEAE cellulose column and fractionated by a step
gradient of NaCl and urea.
process was buffer A.

The first buffer used in the fractionation

The second buffer, B, contained 0.04 M imidazole
16
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_ HCl, pH 7.0, 0.3 M NaCl, 0.01 M MgC1 2 and 0.1 mM EDTA.
density of the eluents was monitored at 260 nm.

The optical

Peaks of increased

optical density were seen in fractions collected from buffers A and B.
The absorbance of the washes from both buffers were allowed to level to
o.Ol A260 units before a change of buffer was made.

The last buffer,

used to elute the tRNA from the column, contained 0.04 M imidazole HCl, pH 7.0, 1.0 M NaCl, 4M Urea, 0.01 M MgC1 2 and O.lmM EDTA.

All

fractions with an absorbance of greater than 0.5 at 260 nm, were pooled
and precipitated with two volumes of cold ethanol.

The preparation was

stored at -20°c.

Preparation of Crude Yeast Enzyme Extract
Yeast cells were either lysed with toluene (Laten, 1978) or
mechanically disrupted with glass beads.

In the first method of cell

lysis, 100 ml of ice cold toluene was added to 50g of frozen yeast
cells.

The yeast paste was allowed to soften, after which the sus-

pension was frozen in dry ice for 2 hours.

Excess toluene was poured

off and the frozen paste was allowed to thaw overnight at 4°C.
2 MTRIS was added to the thawed suspension.
using the bead beater

2 ml of

In the second method,

(Biospec Products) for cell disruption, 2 M TRIS

was added to the yeast paste in the proportion of 2 ml TRIS per gram wet
weight of cells.

The cells were homogenized in 1 minute intervals for a

total of 3 minutes.
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Following breakage by either method as described above, the
homogenate was centrifuged for 20 minutes at 30,000g.
was recentrifuged for another 10 minutes at 30,000g.

The supernatant
The supernatant

was then dialyzed exhaustively against 0.02 M TRIS - HCl, pH 7.5,
o.3 M KCl, 0.01 M MgC1 2 and 0.1 mM EDTA.

The preparation was then

concentrated by ultrafiltration (Immersible CX-10), and stored in 0.5 ml
or 1.0 ml aliquots at -20°c.

Preparation of Enzyme Extract Enriched for Isopentenylpyrophosphate:
tRNA isopentenyl transferase
Initially yeast cells were disrupted by grinding with a mortar and
pestle and alumina.

lOg of alumina was added to lOg of frozen yeast

paste and ground for about 30 minutes.

10 ml of buffer D (0.05 M TRIS -

HCl, pH 7.5, 0.005 M MgC1 2 , 0.02 Mmercaptoethanol) were slowly added to
the yeast suspension during the grinding process.
was centrifuged at 30,000g for 20 minutes.

The yeast suspension

The supernatant was recen-

trifuged an additional 10 minutes at 30,000J!..

The enrichment process

from this point on, parallels the enzyme preparation of Kline
(1969).

et~

The supernatant was brought to 45% saturation with ammonium

sulfate.

The ammonium sulfate (25.Sg/100 ml solution) was stirred in

the supernatant for 10 minutes at

o0 c.

The precipitate formed was

removed by centrifugation at 15,000..[ for 20 minutes.

To the super-

natant, ammonium sulfate (60%, 9g/100 ml) was added and stirred for 10
minutes at

o0 c.

The precipitate was separated by centrifugation at
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15 ,0001 for 20 minutes.

The pellet was then dissolved in a minimal

volume of buffer D and dialyzed overnight against 2 liters of the same
buffer.

A total of 3 changes of the dialysis solution was made.

The

enzyme preparation, packed in an ice-bath, was then concentrated using
millipore ultrafiltration units (Immersible CX-10).

Aliquots of the

enzyme preparation were stored at -20°c.
In a second method of preparation for an enzyme extract enriched
for isopentenyltransferase, the cells were disrupted using a beadbeater.

Yeast pellets were homogenized in an ice-chilled bead beater at

15 second pulses followed by a 30 second cooling period for a total
homogenization time of 5 minutes.

The homogenate was decanted.

The

glass beads were washed with buffer D and the wash added to the previously decanted homogenate.
15,000.[ for 20 minutes.

The combined extracts were centrifuged at

The pH of the supernatant was checked and

adjusted to pH 7.5 with 2 N ammonium hydroxide.

The supernatant was

brought to 15% saturation (8.5 g/100 ml) with ammonium sulfate and
stirred for 10 minutes at

o0 c.

The precipitate was removed by centrifu-

gation at 15,000..[ for 20 minutes.

To the supernatant, ammonium sulfate

was added (90% saturation, 55.6 g/100 ml) and again stirred for 10
minutes at o 0 c.

The precipitate was then collected by centrifugation

(15,000g for 20 minutes) and dissolved in a minimal volume of buffer D.
The enzyme was concentrated using a millipore ultrafiltration unit
(Immersible CX-10).
-20°c.

Aliquots of the enzyme prepar-ation were stored at
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Assay for Isopentenylpyrophosphate Isomerase Activity
The isomerase assay was a modification of the assay used by
Agranoff

!.!~·

(1960).

For the assay, 1.5 _µmoles MgC1 2 , 1.0 µmole
TRIS, pH 8.0, 0.05 µmoles D.. 3-isopentenylpyrophosphate, 0.90 nmole
[14c] - 1:::, 3-isopentenylpyrophosphate (53 mCi/mmole), 50 µl of crude
yeast enzyme extract in a total volume of 500 µl were incubated at
37°c.

[Protein concentrations of enzyme preparations obtained from wild

type strain were 20 mg/ml and 62 mg/ml for the mod5-1 strain as measured
by Lowry protein assay (1951)].
30, 60 and 120 minutes.

50 µl aliquots were taken at 0, 10,

To each aliquot, an equal volume of 6% cold

trichloroacetic acid was added to destroy the acid labile product and to
stop further enzymatic reaction.

The sample was then extracted with

440 µ l of ether and centrifuged for 1 minute to separate the two
phases.

The ether layer was removed and 50 µl of the aqueous layer was

transferred to a 2.4 cm glass fiber disc, allowed to dry and counted by
liquid scintillation.

The glass fiber discs were counted either in a

xylene base medium (a product of Amersham) or a toluene based scintillation medium with 4.5g PPO and 0.09g POPOP per liter of toluene.

Assay for tRNA Isopentenylpyrophosphate:
tRNA isopentenyl transferase
The transferase assay was a modification of the assay used by Kline
!!~. (1969).

The mixture for assaying transferase activity contained
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75 µmoles of TRIS-HCl, pH 7 .5, 9 µmoles of MgC1 , 3 µmoles of f3
2
14
3
mercaptoethanol, 45 nmoles of [ cJ- ~ -isopentenylpyrophosphate,
crude yeast enzyme extract

(5

-

mg protein), mod5-1 tRNA (30 O.D. units),

enriched enzyme preparation (30 mg) in a total volume of 1.5 ml.
The initial reaction mixture (without tRNA and enriched enzyme
preparation) was incubated at 37°C for 45 minutes to allow for the
3
conversion of 6. -i sopentenyl pyrophosphate to b. 2-i sopentenyl pyrophosphate.

Two aliquots, 50 µl each, were taken at O and 30 minutes to

monitor the isomerase activity.

mods~1

tRNA and the enriched enzyme

preparation were then added to the incubated mixture in a final volume
of 1.5 ml.

At various times, 300 µ.l aliquots were removed from the

incubation mixture and immediately immersed in ice to stop the reaction.
Samples were then loaded onto pre-equilibrated DEAE cellulose columns
made from Pasteur pipettes (length of column was 6 cm).

The tRNA was

isolated from the column by a step gradient of NaCl and urea as
described eariler under "Isolation of mod5-1 tRNA".

The columns were

washed with 20 ml of buffer A and 5 ml of buffer B.

5 ml of buffer C

were used to elute the tRNA from the column.

The tRNA was precipitated

overnight with 2 volumes of ice-cold ethanol at -20°c.

The precipitate

was isolated by centrifugation at 10,000.[ for 10 minutes, and dissolved
in 2 ml distilled deionized water.

100 µ l of the sample was placed

into vials containing 10 ml of Aqueosol and counted by liquid scintillati on.
A second modification of the transferase assay used by Kline
(1969) was made.

et~·

In this assay, the incubation mixture contained: 40
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nmoles of [ 14 cJ- 6. 3-isopentenylpyrophosphate, crude yeast enzyme
extract (0.5 mg protein), tRNA (20 O.D. units), and buffer A in a final
volume of 2 ml.

The mixture was incubated at 37°C.

At various reaction

times, 0, 30, 60, 120 and 240 minutes, 400 pJ of the mixture was
sampled and placed into pre-chilled vials.

The samples were then loaded

onto pre-equilibrated DEAE cellulose columns and the tRNA eluted from
the column by a step gradient of NaCl and urea.

10 ml of buffer A, and

10 ml of buffer B were used to wash the column.

The tRNA, eluted with

buffer C, was collected in one 1.3 ml fraction and four 2.0 ml fractions.

Each of these fractions was precipitated overnight with twice

the volume of cold ethanol at -20°c.

The precipitate was collected by

centrifugation at 15,000_[ for 20 minutes.

The precipitate was then

dissolved in 200 µl of distilled deionized water.

200 µl of the

dissolved sample was placed into vials containing 5 ml of scintillation liquid (Ready-Solve EP) and counted by liquid scintillation.

General
Cold t:, 3-isopentenylpyrophosphate was a gift of Dr. D. Poulter,
[ 14 cJ- 6. 3-isopentenylpyrophosphate with a specific activity of 53
mCi/mmol e was a product of Amer sham. For the tRNA i sopentenyl trans14
3
ferase assays, the [ cJ- 6. -isopentenylpyrophosphate used was either
a product of Amersham (53 mCi/mmole) or New England Nuclear
(50.4 mCi/mmole).
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Counting of Radioactivity
All samples were counted in a Packard Tri-Carb 300 liquid scintillation counter.

Quantitation of Protein
Quantitation of protein was done using the Lowry protein assay
(1951).

The standard used was bovine serum albumen.
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RESULTS AND DISCUSSION
Determination of Isopentenylpyrophosphate
Isomerase Activity in Wild Type and Mod5-1 Yeasts
In the isomerase assay, loss of radioactivity in the aqueous layer
after the ether extraction is indicative of the amount of conversion of
l:::. 3-ipp to ~ 2 -ipp by the isomerase enzyme present. !::,. 2-ipp is acid
labile whereas .6 3-ipp is stable in acid. The addition of trichloro2
acetic acid causes the breakdown of the L\ -ipp and the ether extracts
breakdown products from the aqueous layer. Therefore, as conversion of
~ 3-ipp to ~ 2 -ipp progresses, decreasing radioactive counts will be
observed in the aqueous layer.
Increasing isomerase enzyme concentration or the reaction time will
have the same effect of increasing the extent of conversion of b. 3-ipp
to D.. 2-ipp. Initially, several preliminary assays were done using
varying concentrations of crude yeast enzyme extract from the wild type
strain and a constant reaction time.
tions of the assay used by Agranoff

These assays were all modifica
et~·

(1960}.

The incubation

mixture initially contained 1 nmole [ 14 cJ- ~ 3 -ipp (6,000 c.p.m.) in
10 mM TRIS-HCl, pH 8.0, 15 mM MgC1
20 µ1.

(buffer E) in a final volume of
2
Incubation was at 37°c for 30 minutes. The protein concentra-

tions used, ranged from 0-0.2 mg.

The expected results would be an

observation of decreasing radioactive counts with increasing protein
concentration.

The observed results though, (Table 1), did not reflect
25
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this trend.

In Assay 1.1, two samples with 50 pg and 100 µg of

protein showed higher radioactive levels than the sample with no protein
added.
p.g.

In Assay 1.2, less protein was used, ranging from 0
Results were equally inconclusive.

containing 16

µg

µg

to 33

The drastic drop in the sample

protein was probably due to a sampling error.

In

Assay 1.3, with concentration of protein used ranging from 0 µg to
8 µ g, only one sample (with 6 µ g of protein), showed less acid stable
radioactivity level than the sample containing no protein.
exception of the sample containing 0.2
expected trend was observed.

).lg

With the

protein in Assay 1.4, the

The decrease in radioactive counts,

however, was far less than expected.
At this point, a slightly different approach was taken.

Assays

were done using a constant enzyme concentration, but sampled at varying
times.

Since all samples were taken from only one reaction mixture,

this approach minimized errors that might be introduced in aliquoting
materials for the incubation mixtures. The reaction contained 10 nmoles
of b. 3-ipp, in buffer E in a final volume of 200 µl. Results are
summarized in Table 2.

The expected pattern of decreasing counts with

time was not observed.
The substrate concentration of .6. 3-ipp was next increased. In a
total volume of 6 µl of buffer E, 1 nm [ 14 cJ- ~ 3 -ipp (6,000 c.p.m.)
was incubated with 2 µ.g of wild type yeast enzyme extract.

The

observed results, summarized in Table 3, were not consistent with the
expected.

The assay was repeated with the final volume of buffer E
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increased to 24 µ.l.
sive.

The results from this assay were also inconclu-

The minor reductions in substrate radioactivity after 60 minutes

were of questionable significance.
We speculated that unacceptable high background levels of radio
activity from products might be responsible for our inconclusive results
and accordingly incorporated nonradioactive t:. 3-ipp in the assay. In
the following assays, sop.moles (0.10 mMolar) of both radioactive and
nonradioactive 6. 3-ipp was used. The specific activity of [ 14 cJ- D. 3ipp was reduced from 53 mCi/mmole to 0.10 J-1.Ci/ J-lffiOle in Assay I and
to 0.95 p..Ci/ µmole in Assays 4.2 - 4.7.
results of the assays.

The assays all showed significant decreases of

radioactive counts with time.
sented in Figure 3.

Table 4 summarizes the

The results of the assays are also pre-

The specific activity of the isopentenylpyrophos-

phate isomerase, calculated from the initial decrease in substrate, was
determined for both the wild type and modS-1 enzyme preparation (Table
4).

A unit of isomerase is defined as the amount of enzyme which
0

catalyzes the isomerization of 1 nmole of substrate per hour at 37 C.
The specific activity of ipp isomerase in the wild type calculated from
Assays 4.1, 4.2, 4.6 and 4.7 ranged from 1.6 units/mg to 13 units/mg.
The ipp isomerase in mod5-1, calculated from Assays 4.4 and 4.5, gave
specific activities of 0.87 units/mg and 2.7 units/mg respectively.
is clear here that the mod5-1 specific activity of 2.7 units/mg falls
within the range of the specific activity of the wild type isomerase.

It
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With this overlap in range of the specific activities in wild type
and modS-1, we concluded that the ipp isomerase is functional in the
modS-1 strain.
From these results it appears even more likely that b. 2-isopentenylpyrophosphate:tRNA- /:::;. 2-isopentenyl transferase is the enzyme that is
deficient in modS-1.

The isomerase reaction provides the basis for the

reaction conditions in the transferase assay.

In the transferase assay,

tRNA was added as substrate for the transferase enzyme.

-mercaptoe-

thanol, a reducing agent, was also introduced into the reaction mixture.
Assays 4.6 and 4.7 were compared to determine the effects of
toethanol on the isomerase reaction.

-mercap-

The wild type enzyme extracts used

in both assays were from the same batch, and the experiments were
carried out simultaneously.

The isomerase activity with 0.01 mMolar /3 -

mercaptoethanol present (Assay 4.6) was determined to be 3.1 units/mg.
Without,B -mercaptoethanol, the specific activity as determined from
Assay VII was 1.6 units/mg.

The specific activity of the ipp isomerase

with mercaptoethanol present was about twice the specific activity of
the ipp isomerase without the mercaptoethanol.

The difference in the

activities, although of questionable signficance, is interesting
especially in view of the findings of Sagami and Ogura (1983).

They

were able to separate four isopentenylpyrophosphate isomerases from
avian liver homogenates using DE-52 cellulose column chromatography, and
found that 1 mM /3 -mercaptoethanol activated at least two of these
isomerases.

29
2
Determination of /;:,. -isopentenylpyrophosphate: tRNA- b. 2-isopentenyl
transferase activity in wild type and modS-1 yeasts
In the transferase assay, incorporation oft,. 2-ipp into tRNA can be
3
monitored by using radioactively labelled £:,.. 3-ipp.
,6. -ipp in the
presence of ipp isomerase is converted to ~ 2-ipp. D. 2-ipp is incorporated into tRNA by the action of 6. 2-isopentenylpyrophosphate:
tRNA- 6 2-i sopentenyl transferase ( tRNA-ipp transferase). Attachment of
the 6 2-i sopentenyl group occurs on the N6 position of a specific
adenosine residue of the tRNA (Kline

et~-·

1969).

Several preliminary experiments, all modifications of the transferase assay used by Bartz
results.

et~-

(1969), did not give the expected
Using radioactive 6 3-ipp, incorporation of the .D. 2-ipp into

the tRNA should result in an increase in radioactive tRNA taken from the
incubation mixture with time.
In the first trial, 150 µmole of TRIS-HCl, pH 7.5, 30 µ.moles of
MgC1 2 , 30 µmoles of ,8-mercaptoethanol, 30 A260 units of tRNA from
modS-1, 12 nmoles c14 cJ- !J. 3-ipp (78,000 c.p.m.) and 90 mg of crude wild
type enzyme in a final volume of 3 ml, were incubated at 37°c.

Aliquots

taken at intervals were extracted with phenol and tRNA in the aqueous
phase was precipitated on glass fiber discs with cold trichloracetic
acid, washed in ethanol and trichloroacetic acid, and counted.
Table 5 summarizes the results of the initial transferase assays.
In Assay 5.1, the increases in radioactive counts at 60 and 90 minutes
were not significant and background levels were highly variable.
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In several experiments that followed, various parameters such as
the subtrates ( 6 3-ipp and tRNA) and enzyme extract concentrations were
varied. In Assays 5.2, 5.3, and 5.4, the concentration of 6. 3-ipp was
increased to 13.3 A260 Jml, and the enzyme extract used ranged from
3 to 20 mg. Results were equally inconclusive. The radioactive counts
in Assay 5.7, a control containing no tRNA, were fairly constant.
Sampling though was done in triplicate, and too much variation was seen
within the sets of triplicates for the results to be deemed significant.
Assays 5.6 and 5.10 showed the expected trend of increasing counts with
time but were considered inconclusive for the same reason.
In an attempt to boost the concentration of the tRNA-ipp transferase enzyme, the crude yeast extract was enriched for tRNA-ipp
transferase using a modification of the protocol of Kline

et~·

(1969).

[See the first method of enriched enzyme preparation in "Materials and
Methods".]

These workers found the transferase activity of the enriched

preparation to be nine times greater than the crude extract.

The

results of Assays 6.1 - 6.10 are summarized in Table 6. In assays 6.1
and 6.2, the specific activity and concentration of L'.l 3-ipp was
maintained at 0.95 µCi/ µmole and 0.02 mM respectively.

Both crude

wild type enzyme extract (5 mg) and the enriched preparation (10 mg)
were used.

The results of Assays 6.1 and 6.2 were inconclusive.

We felt that it was necessary to allow time for the conversion of
Ll 3-ipp to A 2-ipp before introducing tRNA and the tRNA-ipp transferase
enriched preparation into the incubation mixture.

With this in mind,

the mixture was incubated at 37°c for 45 minutes prior to addition of
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tRNA and the enriched enzyme preparation.

The isomerase reaction was

also monitored.

For all isomerase reactions monitored, between 70% 80% conversion of D.. 3-ipp to .6. 2-ipp was observed within 60 minutes of
incubation at 37°C.
Even with the above modifications, the Assays 6.3 and 6.4, did not
give the expected results.

The inconclusiveness of the observed data,

we felt, was largely due to excessive background.

Kline et!}_. (1969),

encountered similar problems in their attempts to assay the incorporation of radioactivity into tRNA by precipitation with either perchloric
acid or trichloroacetic acid.

They also found that extensive washing

and reprecipitation failed to remove the contaminating radioactivity.
For the next set of assays, a different technique was used to isolate
the tRNA.

Isolation of tRNA was done using DEAE cellulose columns.

Elution of tRNA was achieved with a step gradient of NaCl and urea as
described in ''Materials and Methods."
are summarized in Table 6.

The results of Assays 6.5 - 6.10

Both the mod5-1 (Assays 6.7 - 6.8) and the

wild type strain (Assays 6.5, 6.6, and 6.9) showed increases in radioactive levels relative to the sample taken at O time.

However, contrary

to expectations, the increase in counts was more dramatic in the mod5-1
strain than in the wild type.

In Assay 6.8, monitored for the first two

hours, an increase in radioactive counts was seen at 45 minutes followed
by a drastic decrease at 120 minutes for the mod5-1 strain.

The wild

type strain on the other hand (Assay 6.9), showed a steady increase of
radioactive counts for the same duration of time.

Since ipp isomerase

was found to be functional in mod5-l, the likely candidate for the
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deficient enzyme in mod5-1 is tRNA-ipp transferase.

This being the

case, incorporation of tRNA should be less dramatic or even non-existent
in the mod5-1 strain as compared to the wild type.
One possible explanation for the above contradictory observations
could be the presence of tRNAs in the enzyme preparations.

The wild

type enzyme extract differed from the mod5-1 enzyme extract in one
respect; the presence of fully modified tRNAs.

The isopentenylation of

the unmodified tRNAs was possibly inhibited by the presence of fully
modified tRNAs.

Crude mod5-1 enzyme extract preparation on the other

hand, is not contaminated with fully modified tRNAs.

In essence, this

has the effect of increasing the concentration of the substrate tRNA in
the incubation mixture.

Bartz

et~·

(1970) using a partially purified

E.coli enzyme found the incorporation of isopentenyl groups into tRNA to
be linearly proportional to tRNA concentration.

Allowing for the

presence of some enzymic reaction in mod5-l, the two factors mentioned
could lead to an observed enhancement of incorporation of b.. 2-ipp in
mod5-1 relative of the wild type.
The next set of assays were done using a relatively nucleic acid
free enriched enzyme preparation.

The contaminating tRNA was removed

from the enriched enzyme preparation by precipitating out the protein
with ammonium sulfate.

(See the second method of enriched enzyme

preparation in "Materials and Methods.")
The tRNA, eluted from DEAE cellulose columns with 1.0 M NaCl and
4.0 M urea, was collected in five different fractions.

In nearly all

cases, the tRNA eluted in the first 3 fractions in Assays 7.1 and 7.6
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were combined and the results summarized in Tables 7A and 7B.

Results

of Assays 7.1, 7.2, 7.3, and 7.4 are also shown in Figure 4.
Significant incorporation of the radioactively labelled isopentenyl
group was seen in the wild type strain (Assays 7.1 and 7.2).

Two

different strains of mod5.1 were used in the transferase assays.

Strain

number 1320 showed no incorporation of the isopentenyl group into the
tRNA, indicating total absence of transferase activity.

Assay 7.4

(strain number 43) showed very slight incorporation at 30, 60, 240
minutes and 0 incorporation at 120 minutes.
A unit of tRNA-ipp transferase was defined as that amount of enzyme
incorporating 1 pmole of 6. 2-isopentenyl pyrophosphate into 20 A260
units of tRNA in 1 hour. By this definition, the specific activity of
the tRNA-ipp transferase for the wild type was 1.4 units/mg for Assay
7.1 and 0.64 units/mg for Assay 7.2.

The specific activity for mod5-1,

strain number 43 was 0.12 units/mg and O units for strain number 1320.
The specific activities calculated for tRNA-ipp transferase were the
result of observations made of two coupled reactions; the conversion of
6 3-ipp to .6. 2-ipp and the incorporation of the b,. 2-ipp into tRNAs.
These values we feel can only be accepted as rough approximations.
In Assays 7.5 and 7.6, the tRNA substrate used was from fission
yeast.

The fission yeast used was a sin 1 mutant that lacked

isopentenylated tRNAs.

In Assay 7.5 using wild type enzyme, generally

no incorporation was observed (isopentenylation was observed to a small
degree at 30 minutes).

The tRNA-ipp transferase in baker 1 s yeast

appears incapable of catalysing the isopentenylation of undermodifiea
T

.,,j

,

~"'''"<

-.,

•'

-'
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tRNAs in fission yeasts.

In Assay 7.6, with mod5-l enzyme, as expected

no incorporation was observed.

The sample tRNA taken at O time,

however, showed a very high radioactive level.

This observation could

only be attributed to an error, but the nature of this error could not
be determined.
In summary, this study suceeded in identifying the missing gene
product in mod5-l, a yeast mutant lacking isopentenylated tRNAs.

It was

theorized that the missing gene product was probably an enzyme based on
the fact that the mutation is recessive.

The most likely candidate for
the defective enzyme was ~ 2 -isopentenylpyrophosphate:tRNA- 6 2isopentenyl transferase.

Another possible candidate, although unlikely,

was isopentenyl pyrophosphate isomerase, the enzyme catalyzing the
reaction one step upstream in the pathway for the synthesis of
isopentenylated tRNAs.

The results of the isomerase assays indicated

that the isomerase enzyme was active in mod5-1.

However, the trans-

ferase assays revealed that mod5-l lacked transferase activity; showing
a complete absence of isopentenylation of the tRNAs in one strain of
mod5-l and marginal activity in another when compared to the wild type.
We concluded that our initial hypothesis was correct; the£::,.. 2isopentenylpyrophosphate:tRNA- ~ 2 -isopentenyl transferase was indeed
the deficient gene product in mod5-1.
tRNA-ipp transferase does not appear to play a vital role in
yeasts.

Isopentenylation is not required for growth in yeasts, with the

mod5-l mutation showing no effect on growth of the mutants.

The growth
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of the mutants showed little difference from the wild type in terms of
cell yields and generation time (Laten
The effect on protein

et~··

synthesis~

1978).

vivo is quite subtle and

requires sensitive monitoring based on antisuppression.

Despite the

fact that this enzyme and its product appear to be dispensable, they may
be of great significance when reviewed on evolutionary time scales as
opposed to laboratory ones.
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TABLE 1

Assay

Amount of protein

0

50

100

150

200

c.p.m.

37.989

59,943

41,193

31,666

30,072

Amount of protein

0

6

16

c.p.m.

34 .599

22,181

1,536

Amount of protein

0

2

4

6

8

35, 177

35,613

55,015

31,800

57,439

0

0.2

0.4

0.8

2.1

28,078

20.357

26,399

25,610

21,951

g

1

Assay

21

33

g

2

Assay
3

23,064

g

c.p.m.
Amount of protein

Assay

32. 715

g

4

c.p.m.

Assay for isopentenylpyrophosphate isomerase:
Each assay contained 1 nm[ 14 cJ- A 3-ipp, 0.3 µmole MgC1 2 ,
0.2 µmole TRIS, ph 8, and distilled deionized water in addition
to the different concentrations of wild type yeast enzyme extract.
Incubation was for 30 minutes at 37°C.

TABLE 2

Amount
of
protein
( )Ag)

Incubation Time (minutes)
0

30

60

90

120

2

27,910

22,497

21,787

18,343

22,196

3

21,599

21,945

24, 716

21,049

20,229

2

24,270

25,520

27,837

--

23,854

(Boiled)

Assay for isopentenylpyrophosphate isomerase:
Each assay contained 10 nmoles[ 14 cJ- .:".). 3-ipp,
3 p. moles MgC1

0.5 µmoles TRIS, pH 8.0, wild
2
type yeast enzyme extract and distilled deionized

water in a final volume of 200 µl.
was at 37°C.

Incubation

Values given are in c.p.m.

w

-.....J

TABLE 3

Assay

Amount
of
Protein
( pg)

Final
Volume

(µ

Incubation Time (minutes)

1)

0

15

60

(i )

2

6

3,730

4,413

3,063

(ii)

4

24

12,983

10 ,469

10,935

Assay for isopentenylpyrophosphate isomerase:
(i) Assay contained 1 nmole [ 14 cJ- [),. 3-ipp, 0.8 p. mole
MgC1 2 , 0.5 µmole TRIS-HCl, pH 8.0, wild type yeast
enzyme extract and distilled deionized water.

Incu-

bation was at 37°c.
(ii) Assay contained 4 nmoles [ 14 cJ- 6 3-ipp, 3 µmole
MgC1 2 , 2.0 µmole TRIS-HCl, pH 8.0, wild type yeast
enzyme extract and distilled deionized water.

Incu-

bation was at 37°C.
Values given are in c.p.m.

w

CX>

TABLE 4

Assay

Pre para ti on

Protein
(mg)

Counts Per Minute
0

10

30

60

120

Specific Activity
~uni ts/mg)*
4.3

1

~Enzyme

1.0

304

--

68

48

31

2

~

1.0

3,328

l,03S

742

622

soo

13

3

Boiled

1.0

4,1S9

--

3,966

4,133

--

0

4

~Enzyme

3.0

l,7S6

308

2S6

222

242

2.7

s

~Enzyme

3.0

1,872

--

48S

302

--

0.87

~Mercaptoethanol

1.0

2,678

2,137

1,264

659

--

3.1

MODS+ Enzyme
without Mercaptoethanol

1.0

2,733

2,433

1,460

654

--

1.6

6

7

Enzyme
~Enzyme

MODS+ Enzyme

Assay for isopentenylpyrophosphate isomerase:
E.\ch assay contained SO µmoles of fl 3-ipp, 1.5

moles MGC1 2 , 1.0 _µmole TRIS-HCl, pH 8.0, crude yeast enzyme extract and
distilled deionized water in a final volume of SOO µ1. Incubation was at 37°C.
*A Hnit of isomerase is defined as the amount of enzyme which catalyzes the isomerization of 1 nmole of substrate per hour at
37 c.

TABLE 5

Final
Volume

6 3-ipp

Mod5-l
tRNA
A260

Protein
(mg)

0 min

Counts Per Minute

(µ1)

(mMolar)

15 min

30 min

60 min

1

3000

0.004

30

90

125

140
(60 min)

131
(90 min)

98
(120 min)

2

1500

0.1

20

3

135+34

65+17

42+11

59+ 3

3

1500

0 .1

20

3

155+38

148+33

113+ 12

77+19

4

1500

0.1

20

20

154+29

49+ 5

25+ 4

16+ 7

5

1500

0.02

200

2

348+159

165+37

185+88

161+25

6

1500

0.02

200

4

95+ 9

108+15

108+18

2R3+71

7

1500

0.02

0

4

82+24

52+26

82+40

8

1500

0.02

200

10

328+15

103+ 6

93+16

103+ 8

9

1500

0.02

0

10

681+55

---

819+970

85+16

10

1500

0.02

200

20

82+31

288+32

236+26

195+ 8

Assay

tRNA - ipp transferase assay: In addition to [ 14 cJ - ti 3 - ipp, tRNA, and enzyme extract
TRIS-HC1, PH 7.5, 0.01 H Mg c1 and 0.01 M,s - Mercaptoethanol. The specific activity of
2
to 5.4 was 53
mCi/nwnole and 0.95 µCi/ f'mole in Assays 5.5 to 5.10. Aliquots taken at
phenol and the tRNA precipitated on glass fiber discs and cold trichloroacetic acid. The
trichloroacetic acid and counted.

86+104

and each assay contained 0.05 H
14
3
[ cJ - I:!.. - ipp in Assays 5.1
intervals were P.xtracted with
discs were washed in ethanol and

TABLE 6

Assa)

(mMolar)

modS-1
tRNA
A260

1

0.02

100

2

0.02

0

3

0.03

30

4

0.03

30

s

0.03

18

6

0.03

7

A3 -ipp

Yeast
Strain

Protein
Extract
Crude

(mg)
Enriched

Counts Per Minute
0 min

lS min

30 min

4S min

60 min

120 min

s

10

134+ 2

102+6

94+ 0

--

69+ 6

--

0

10

198+13

--

--

66+,2

--

3

3

S67+10

---

341+94

--

292+10

--

s

30

l,98S+503

--

2,655+699

--

2,653+2,192

--

MODS+
·--

2.S

30

102

--

--

239

--

--

30

-MODS+

5

30

128

--

--

258

--

--

0.03

30

modS-1

5

30

139

--

--

594

--

8

0.03

30

modS-1
---

30

417

767

--

1,011

378

9

0.03

30

MODS+
--

s
s

---

30

SlS

S70

--

628

--

740

10

0.03

30

Boiled
Enzyme

5

30

S53

SS3

--

--

--

534

MODS+
-

MODS+
--

,____._
. .
3
C] - ~ - ipp, tRNA, enzyme extract, 0.05 M TRIS-HCl, pH 7 .5, 0.01 M
MgC12 and 0.01 M ~ - Mercaptoethanol 1n a final volume of 1500 µl. The specific activity of the [ 14 c] - fl 3 - ipp in Assays
tRNA - ipp transferase assay:

5.1 and 6.3 were 0.9S
(i)

Each assay contained [

µCi/ p.mole and 53

mCi/ntnole

14

in Assays 6.4 to 6.10.

Incubi\tion was at 37°C.

In Assays 6.1 and 6.2, the sampled tRNA was extracted with phenol, precipitated with cold trichloroacetic acid and
counted.

(ii)

In Assays 6.3 to 6.10, the incubation mixture wi\s allowed to incubate for 45 minutes before the i\ctrtition of tRNA and
the enriched enzyme preparation.
*( i).

(iii)

Isolation of tRNA was done using trichloroacetic acid precipitation as described in

*In Assays 6.5 to 6.10, the tRNA was isolated using DEAE cellulose columns (See "Materials and Methods").

TABLE 7A

·-

Assay

tRNA
Subtrate

Yeast
Strain

Protein
Extract
Crude

Counts Per Minute
(mg)
Enriched

0 Min

30 Min

60 Min

120 Min

240 Min
'

1

mod5-1

MOD5+

0.5

4

131

288

292

320

--

2

mod5-1
---

MODS+
-

0.5

10

80

261

396

--

--

mod5-l

modS-1
\1320)

0.5

10

0

0

0

0

--

3

----

-

4

mod5-1

modS-1
{
43)

0.5

10

18

50

56

12

42

5

Fission

·--

MODS+

0.5

10

63

125

17

52

40

6

Fission

modS-1
(
43)

0.5

10

866

0

35

0

2

-·

·tRNA - ipp transferase assay:

See "Materials and Methods" for the assay conditions.

+'>
N

TABLE 7B

Assay

tRNA
Substrate

Yeast
Strain

Protein
Extract
Crude

!pp incorporated into 20 O.D. Units of tRNA (p moles)
(mg)
Enriched

O min

30 min

60 min

-

120 min

240 min

'

1

mod5-1

MOD5+

.5

4

0

2.8

2.9

3.4

--

2

mod5-1

MOD5+

.5

10

0

3.2

5.6

--

--

3

mod5-1

mod5-1
{ I320)

.5

10

0

0

0

0

--

-·

I---

4

mod5-1

mod5-1
{
43)

.5

10

0

0.6

0.7

0

0.4

5

Fission

MOD5+

.5

10

0

1.1

0

0

0

6

Fission

mod5-1
{
43)

.5

10

0

0

0

0

0

Transferase Assay:
!pp incorporation into 20 O.D. units of tRNA.
Zero time incubation has been subtracted.

+:>
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FIGURE 3
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Gontrol

30
0
0

-x

E
CL

0
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5-1
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0
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80

100

12.0

140

Tl me (mi n )

Fig. 3 Isopentenylpyrophosphate isomerase assays.
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FIGURE 4

40

Mod5 + (5

35

m5l

?J)

'2S
0

-

M od 5 + (2. .

)(

m3 )

E
c::L

\5

IS

10

5

Mod5+ (Pission t.RNA\
r---:;;~~~~~~~~=::::::::,,.._-=-~-

0

2.0

40

bO

100

M od

\U)

5-\
\40

(i=t43)
lbO

Time (min)

Fig. 4

Isopentenylpyrophosphate: tRNA isopentenyl transferase assays.
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